1. Home
  2. SKIL vs RNXT Comparison

SKIL vs RNXT Comparison

Compare SKIL & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

HOLD

Current Price

$6.18

Market Cap

40.2M

Sector

Technology

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.88

Market Cap

38.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKIL
RNXT
Founded
1998
2012
Country
United States
United States
Employees
2247
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
38.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SKIL
RNXT
Price
$6.18
$0.88
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
132.2K
220.3K
Earning Date
04-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$1,123,000.00
Revenue This Year
$0.11
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$3.43
$0.70
52 Week High
$18.45
$1.45

Technical Indicators

Market Signals
Indicator
SKIL
RNXT
Relative Strength Index (RSI) 43.36 44.67
Support Level $4.92 $0.81
Resistance Level $8.34 $0.98
Average True Range (ATR) 0.68 0.05
MACD -0.10 -0.01
Stochastic Oscillator 30.00 25.06

Price Performance

Historical Comparison
SKIL
RNXT

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: